142 related articles for article (PubMed ID: 26140218)
21. Unravelling the pharmacokinetics of aflatoxin B1:
Lootens O; De Boevre M; Gasthuys E; Van Bocxlaer J; Vermeulen A; De Saeger S
Front Microbiol; 2022; 13():988083. PubMed ID: 36110298
[TBL] [Abstract][Full Text] [Related]
22. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
Lee RP; Parkinson A; Forkert PG
Drug Metab Dispos; 1998 Jan; 26(1):60-5. PubMed ID: 9443854
[TBL] [Abstract][Full Text] [Related]
23. A comparison of hepatic in vitro metabolism of T-2 toxin in rats, pigs, chickens, and carp.
Wu Q; Huang L; Liu Z; Yao M; Wang Y; Dai M; Yuan Z
Xenobiotica; 2011 Oct; 41(10):863-73. PubMed ID: 21745144
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes.
Meakin AS; Amirmostofian M; Darby JR; Holman SL; Morrison JL; Wiese MD
Placenta; 2023 Jan; 131():82-89. PubMed ID: 36527743
[TBL] [Abstract][Full Text] [Related]
25. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
Forkert PG; Lee RP
Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method.
Sun P; Cao Y; Qiu J; Kong J; Zhang S; Cao X
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894672
[TBL] [Abstract][Full Text] [Related]
29. Confirmation of metabolites of the neuroleptic drug prothipendyl using human liver microsomes, specific CYP enzymes and authentic forensic samples-Benefit for routine drug testing.
Krämer M; Broecker S; Madea B; Hess C
J Pharm Biomed Anal; 2017 Oct; 145():517-524. PubMed ID: 28756170
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.
Meyers NL; Hickling RI
Drugs R D; 2008; 9(1):37-63. PubMed ID: 18095752
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
Nielsen LM; Holm NB; Olsen L; Linnet K
Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
33. Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.
Yu C; Shin YG; Kosmeder JW; Pezzuto JM; van Breemen RB
Rapid Commun Mass Spectrom; 2003; 17(4):307-13. PubMed ID: 12569440
[TBL] [Abstract][Full Text] [Related]
34. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
35. Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.
Svensson US; Ashton M
Br J Clin Pharmacol; 1999 Oct; 48(4):528-35. PubMed ID: 10583023
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of (-)-cis- and (-)-trans-rose oxide by cytochrome P450 enzymes in human liver microsomes.
Nakahashi H; Yamamura Y; Usami A; Rangsunvigit P; Malakul P; Miyazawa M
Biopharm Drug Dispos; 2015 Dec; 36(9):565-74. PubMed ID: 26126958
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of T-2 toxin by rat liver carboxylesterase.
Johnsen H; Odden E; Lie O; Johnsen BA; Fonnum F
Biochem Pharmacol; 1986 May; 35(9):1469-73. PubMed ID: 3707611
[TBL] [Abstract][Full Text] [Related]
39. [Interaction of butylphthalide with rat and human liver CYP450 isoenzymes].
Zhao Q; Hu JP; Jiang J; Li Y; Hu P
Yao Xue Xue Bao; 2015 May; 50(5):541-6. PubMed ID: 26234133
[TBL] [Abstract][Full Text] [Related]
40. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
